Oncogenic mutations in PIK3CA are observed in ~7% of non-NF2-mutant meningiomas, and occur mutually exclusive of AKT1 and SMO mutations, although they frequently co-occur with TRAF7 mutations (23). Here, SMO is linked to meningioma.